LSE Department of Health Policy and NICE launch new Executive Master’s programme

LSE Department of Health Policy and NICE launch new Executive Master’s programme

The FINANCIAL -- The London School of Economics and Political Science on 12 July announce a new executive Master’s programme, offering skills in health services research, health economics, outcomes research, and health policy.

The executive MSc in Evaluation of Health Care Interventions and Outcomes will be the first of its kind internationally to offer postgraduate training to professionals in full-time work in this field. It will be run by the Department of Health Policy at LSE, with support from the National Institute for Health and Care Excellence (NICE), which is known internationally for its contribution to the quality and efficiency of health care and the scientific rigour of its approach, according to LSE.

The programme is aimed at professionals from a wide range of backgrounds, including the medical professions, pharmaceutical and medical devices industries, healthcare management, government and non-governmental organisations. It will take two years to complete, with modules held in four intensive two-week periods over two years, meaning that it can be undertaken alongside full-time work.

According to LSE, commenting on the announcement, Professor Paul Kelly, Pro-Director for Education at LSE, said: “The new Executive MSc, designed by the LSE Department of Health Policy in collaboration with NICE, is the first of its kind internationally to address a major demand for expertise in evaluating health care interventions, and will enable students to take the next steps in their careers.”

Professor Elias Mossialos, Head of Department of Health Policy said: “Skills in evaluating health care interventions and outcomes are increasingly important for professionals who want to become active participants in decision-making at all levels. However, until now there has been a lack of postgraduate opportunities tailored to health care professionals in full-time employment. The new Executive MSc will address this gap. The combination of LSE's world-leading teaching and research excellence and NICE’s standing as a national authority and global leader in health technology assessment and guidance development will enable us to offer an unparalleled degree of rigour and professional relevance.”

Sir Andrew Dillon, chief executive of NICE, said: “This is a great opportunity for professionals who are looking to enhance their skills in the healthcare industry. NICE has had nearly 20 years’ experience in evidence-based healthcare decision making and we are excited to be supporting LSE to share our expertise.”

The executive MSc in in Evaluation of Health Care Interventions and Outcomes will open for applications from September 2018 and the course will begin in April 2020.